Thursday, October 01, 2020

Thai FDA preparing to register vaccine as two research teams race ahead

Jun 30. 2020
Facebook Twitter


The Thai Food and Drug Administration is preparing to register any Covid-19 vaccines that are successfully developed in the country.

The World Health Organisation (WHO) is monitoring a total of 142 coronavirus vaccine research programmes worldwide, six of which are being conducted in Thailand.

Of the global total, 13 programmes are at the advanced stage of human trials, while the remaining 129 are at the animal-trial or laboratory stage.

Thailand’s most advanced Covid-19 vaccine programmes are at Chulalongkorn University (mRNA prototype vaccine) and BioNet-Asia (DNA prototype vaccine).

Both prototypes have been tested successfully on animals and are now set to be tested in humans.

A Thai Covid-19 vaccine may be available by early next year, Health Minister Anutin Charnvirakul reported last week.

FDA Deputy Secretary-General Surachoke Tangwiwat said his agency has been in close contact with the Thai research programmes right from the start.

“We have monitored every procedure and step, and have also laid plans for the production of [successful Covid-19] vaccines in the future,” he said.

He added that the FDA was being understanding towards scientists who wanted to skip some steps in the vaccine research for reasons of urgency.

Facebook Twitter
More in News
Editor’s Picks
Top News